Selected article for: "activation contribute and process activation contribute"
Author: Hong, Kyung-Wook; Choi, Su-Mi; Lee, Dong-Gun; Cho, Sung-Yeon; Lee, Hyo-Jin; Choi, Jae-Ki; Kim, Si-Hyun; Park, Sun Hee; Choi, Jung-Hyun; Yoo, Jin-Hong; Lee, Jong-Wook
Title: Lower Respiratory Tract Diseases Caused by Common Respiratory Viruses among Stem Cell Transplantation Recipients: A Single Center Experience in Korea
  • Document date: 2017_3_1
    • ID: k8mn9xkj_21
    Snippet: CRV infection may contribute to sustained inflammation or activation of an inflammatory process that leads to irreversible airway damage, and can cause late airflow obstruction in SCT recipients. 31 Furthermore, CRV infections frequently coexist with bacterial or fungal pathogens, contributing to the development of pneumonia. It may be the result of epithelial damage, impaired ciliary function, an altered immune response, or upregulation of bacte.....
    Document: CRV infection may contribute to sustained inflammation or activation of an inflammatory process that leads to irreversible airway damage, and can cause late airflow obstruction in SCT recipients. 31 Furthermore, CRV infections frequently coexist with bacterial or fungal pathogens, contributing to the development of pneumonia. It may be the result of epithelial damage, impaired ciliary function, an altered immune response, or upregulation of bacterial receptors on the CRV-infected respiratory tract. 16, 32 In addition, there have been several reports that SCT recipients have shown a lower immune response to the influenza vaccine compared with that observed for the general population. 33, 34 Severely immunocompromised patients, such as SCT recipients, have been reported to show prolonged influenza shedding, resulting in the development of antiviral resistance during prolonged antiviral therapy.

    Search related documents:
    Co phrase search for related documents
    • activation sustained inflammation and immune response: 1
    • activation sustained inflammation and sustained inflammation: 1, 2, 3
    • airflow obstruction and general population: 1
    • airflow obstruction and immune response: 1
    • airflow obstruction and inflammatory process: 1, 2
    • airflow obstruction and respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • airway damage and epithelial damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • airway damage and immune response: 1
    • airway damage and influenza vaccine: 1
    • airway damage and irreversible airway damage: 1
    • airway damage and respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • altered immune response and general population: 1, 2, 3
    • altered immune response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51
    • altered immune response and influenza vaccine: 1
    • altered immune response and influenza vaccine immune response: 1
    • altered immune response and respiratory tract: 1
    • antiviral resistance and general population: 1
    • antiviral resistance and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • antiviral resistance and influenza shedding: 1, 2